Who are NKA Bio's investors?

NKA Bio's investors include Techstars, The Innovation Space.

How much funding has NKA Bio raised?

NKA Bio has disclosed $30K raised across 1 round.

Where is NKA Bio headquartered?

NKA Bio is headquartered in Baltimore, US.

NKA Bio

Techstars '24

Baltimore, US · Founded 2023 · Delaware corporation · 2 known investors

nkabio.com ↗

NKA Bio develops antibody-based medicines for critically ill and trauma patients to extend survival time during medical emergencies. The company's lead candidate, NKA01, is an anti-shock toxin antibody administered by emergency medical services to stabilize trauma patients and buy time for transport and surgical intervention.

BiotechHealthtechMedical Devices

Founders & leadership

Lewis C. HibbsNamed on SEC filing

Les E. JohnsonNamed on SEC filing

Susan G. HibbsNamed on SEC filing

Investors · 2

TechstarsBoulder · $220K

The Innovation SpaceWilmington · $200K

Reported raises · per SEC filings

Form D private placements

$30K disclosed across 1 round · 2023

▶$30KraisedApr 2023 · 3 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Lewis C. HibbsExecutive Officer, Director
Les E. JohnsonExecutive Officer, Director
Susan G. HibbsExecutive Officer, Director

Offering amount: $2M
Amount sold: $30K
First sale: Mar 2023
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Docus4 shared keywordsDocus provides an AI layer for diagnostic labs, offering clinical interpretation reports, follow-up recommendations, compliance validation, digital requisitions, and context-aware AI assistants for doctors and patients. It serves direct-to-consumer, reference, and in-house/clinic labs with integration via API/HL7 or its own interfaces.

Brainly4 shared keywordsBrainly provides 1:1 tutoring combining AI explanations with human expert intervention, targeting K-12 students and their parents seeking affordable academic support across all subjects. The platform emphasizes guaranteed grade improvement within 30 days, safety through human supervision of AI interactions, and compliance with education-focused privacy standards.

Companies competing with NKA Bio for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

NKA Bio has filed a notice of an exempt offering of securities to raise $2,000,000.00 in New Equity Investment. - intelligence360intelligence360.news · Apr 2023

Frequently asked questions

What does NKA Bio do?: NKA Bio develops antibody-based medicines for critically ill and trauma patients to extend survival time during medical emergencies. The company's lead candidate, NKA01, is an anti-shock toxin antibody administered by emergency medical services to stabilize trauma patients and buy time for transport and surgical intervention.
Who are NKA Bio's investors?: NKA Bio's investors include Techstars, The Innovation Space.
How much funding has NKA Bio raised?: NKA Bio has disclosed $30K raised across 1 round.
Where is NKA Bio headquartered?: NKA Bio is headquartered in Baltimore, US.